{"id":1833,"date":"2023-03-10T11:44:08","date_gmt":"2023-03-10T06:14:08","guid":{"rendered":"https:\/\/www.cscr.res.in\/symposium\/?page_id=1833"},"modified":"2024-03-21T11:14:06","modified_gmt":"2024-03-21T05:44:06","slug":"scientific-program-2023","status":"publish","type":"page","link":"https:\/\/www.cscr.res.in\/symposium\/index.php\/scientific-program-2023\/","title":{"rendered":"Scientific Program"},"content":{"rendered":"

 <\/h4>\n

\"\"<\/h4>\n

PROGRAMME SCHEDULE                                                                                                                           <\/strong><\/em><\/h4>\n

Time shown in IST (Indian Standard Time) <\/strong><\/em><\/h4>\n

                                             DAY-1: <\/span><\/b>Thursday<\/b>, 31<\/b>st  <\/sup>August, 2023<\/b><\/span><\/h2>\n\n\n\n\n\n\n
1:00 to 1:05 PM<\/td>\nPrayer by Chaplain<\/td>\n<\/tr>\n
1:05 to 1:20 PM<\/td>\n\n

<\/b>Welcome remarks:<\/strong> Director, CMC \/ Director, InStem \/ Principal, CMC<\/p>\n<\/td>\n<\/tr>\n

1:20 to 1:25 PM<\/td>\nRemarks by<\/strong> Dr. Rajesh Gokhale, Secretary, Department of Biotechnology, Ministry of Science and Technology, Govt. of India<\/td>\n<\/tr>\n
1:25 to 1:30 PM<\/td>\nClosing remarks<\/strong>: Head, CSCR<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

                                                                                                           Session-1: CELL THERAPY IN CARTILAGE REPAIR                                                                                                                 <\/strong><\/span>Chair: George Thomas<\/b><\/strong> <\/strong><\/span><\/p>\n<\/td>\n<\/tr>\n

Indian Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
1.30 to 1:55 PM<\/td>\nAutologous Chondrocyte Implantation (ACI): Evolution to current management and clinical outcomes<\/td>\nMats Brittberg<\/strong>
University of Gothenburg, Gothenburg, Sweden<\/td>\n<\/tr>\n
1:55 to 2:20 PM<\/td>\nCartilage regeneration in Osteoarthritis of knee: Reality or myth<\/td>\nPawan Kumar Gupta<\/strong>
Stempeutics Research Pvt. Ltd., Bangalore, India<\/td>\n<\/tr>\n
2:20 to 2:40 PM<\/td>\nPotential of chondroprogenitors for cartilage repair and regeneration<\/td>\nElizabeth Vinod                                                                                                                            <\/strong>Centre for Stem Cell Research (A unit of inStem, Bengaluru) and CMC, Vellore, India <\/td>\n<\/tr>\n
2:40 to 3:00 PM<\/td>\nArticular chondroprogenitors: how close are we to a cell or tissue-based therapy for cartilage repair<\/td>\nIlyas Khan
<\/strong>Swansea University, Swansea, UK<\/td>\n<\/tr>\n
3:00 to 3:15 PM<\/td>\nBreak<\/strong><\/span><\/td>\n<\/tr>\n
3:15 to 3:45 PM<\/td>\nPoster presentation and Industry Exhibition <\/span><\/strong><\/td>\n<\/tr>\n
\n

                                                                                              Session-2:  SAFETY ASPECTS OF GENE THERAPY                                                                                                       <\/strong><\/span>Chair: Vijay Chandru<\/strong><\/p>\n<\/td>\n<\/tr>\n

Indian Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
3:45 to 4:15 PM<\/td>\nPrecision in gene editing: towards next generation tools for therapy and diagnostics<\/td>\nDebojyoti Chakraborty
<\/strong>CSIR Institute of Genomics and Integrative Biology, New Delhi, India<\/td>\n<\/tr>\n
4:15 to 4:45 PM<\/td>\nBase editing and prime editing to treat genetic disease<\/td>\nGregory Arthur Newby<\/strong>
The Johns Hopkins University, Baltimore, US<\/td>\n<\/tr>\n
4:45 to 5:15 PM<\/td>\nUnderstanding the safety or genome-wide activity of CRISPR genome editors for therapeutics<\/td>\nShengdar Q. Tsai<\/strong>
St. Jude Children\u2019s Research Hospital, Memphis, TN<\/td>\n<\/tr>\n
5:15 to 5:30 PM<\/td>\nBreak<\/span><\/strong><\/td>\n<\/tr>\n
                                                                       Session-3: MANUFACTURING AND REGULATORY ASPECTS IN CELL AND GENE THERAPY                                                                  <\/strong><\/span>Chair: Sanjay Singh<\/strong><\/td>\n<\/tr>\n
Indian Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
5:30 to 6:00 PM<\/td>\nCurrent and future trends in gene therapy vector manufacturing<\/td>\nAjay Singh<\/strong>
Gennova Biopharma Ltd., Pune, India<\/td>\n<\/tr>\n
6:00 to 6:30 PM<\/td>\nlentiviral manufacturing for use in phase I\/II clinical trials<\/td>\nDaniela Bischof<\/strong>
Indiana Clinical and Translational Sciences Institute, Indianapolis, IN<\/td>\n<\/tr>\n
6:30 to 7:00 PM<\/td>\nManufacturing of CAR T cells for Point-of-Care treatment of refractory hematological malignancies<\/td>\nRupert Handgretinger<\/strong>
Children\u2019s University Hospital Tuebingen, Tuebingen, Germany<\/td>\n<\/tr>\n
                                                                                                                       <\/b>KEYNOTE<\/b> ADDRESS <\/b><\/span>                                                                                                      <\/b><\/b> Chair: Alok Srivastava  <\/strong><\/td>\n<\/tr>\n
Indian Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
7:00 to 8:00 PM<\/td>\nGene Therapy and Fetal Hemoglobin: Progress Toward a Cure for Sickle Cell Disease<\/td>\nMartin H. Steinberg<\/strong>
Boston University School of Medicine, Boston, USA<\/td>\n<\/tr>\n
End of Day-1<\/span><\/strong><\/td>\n<\/tr>\n
\n

DAY-2: Fri<\/b>day<\/b>, <\/b>1<\/b>st  <\/sup><\/b>SEPTEMBER, 2023<\/b><\/span><\/h2>\n<\/td>\n<\/tr>\n

                                                                                                         Session-4: Industry Updates                                                                                                               Chair: Cartikeya Reddy\u2002<\/span><\/span><\/strong><\/td>\n<\/tr>\n
Indian Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
1<\/strong>.00 to 1:15 PM<\/td>\nCell therapy solutions for every step \u2013 from discovery to cure <\/td>\nPrathap Naidu                                                                                                                            Thermo Fisher Scientific, Mumbai, India<\/td>\n<\/tr>\n
1:15 to 1:30 PM<\/td>\nPresentation on CGT product line of Akadeum Lifescience ,Arcticzymes Technology and BPS Bioscience<\/td>\n\n

Mustansyrr Bohri <\/strong>                                                                                                                      Inveniolife Technology Pvt. Ltd. Mumbai, India<\/p>\n<\/td>\n<\/tr>\n

1:30 to 1:45 PM<\/td>\nEnabling Cell & Gene Therapies from Concept to Patient<\/td>\nGabriel GATA<\/strong>                                                                                                                              Lonza India Pvt Ltd., Gurugram, India<\/td>\n<\/tr>\n
1:45 to 2:00 PM<\/td>\nBreak<\/span><\/strong><\/td>\n<\/tr>\n
                                                                                                      Session-5: IMMUNE CELL THERAPY                                                                                                             Chair: Navin Khattry  <\/span>  <\/span> <\/strong>
<\/strong><\/td>\n<\/tr>\n
Indian Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
2:00 to 2:30 PM<\/td>\nCAR T cell therapy in relapsed\/ refractory B cell malignancies- First Industry sponsored trial from India<\/td>\nSharat Damodar<\/strong>
Mazumdar Shaw Medical Centre, Narayana Health City, Bangalore, India<\/td>\n<\/tr>\n
2:30 to 3:00 PM<\/td>\nManufacturing and clinical testing of allogeneic gamma delta T cells for neuroblastoma and genetic engineering strategies to enhance
their anti-cancer effectiveness<\/td>\n		H. Trent Spencer<\/strong>
Emory University School of Medicine, Atlanta, USA<\/td>\n<\/tr>\n
\n

3:00 to 3:30 PM<\/p>\n<\/td>\n

Chimeric Antigen Receptor \u2013T cells (CAR-T) therapy for hematological malignancies: The Sheba Experience<\/td>\n Arnon Nagler<\/strong>
Chaim Sheba Medical Center, Tel-Hashomer, Israel<\/td>\n<\/tr>\n
3:30 to 3:45 PM<\/td>\nBreak<\/span><\/strong><\/td>\n<\/tr>\n
\n

Session-6: APPLICATIONS OF iPSC TECHNOLOGY  <\/span><\/strong><\/p>\n

Chair- Maneesha S. Inamdar<\/span>
Co-chair: Dhandapani Perundurai<\/span>  <\/span><\/strong><\/p>\n<\/td>\n<\/tr>\n

Indian Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
3:45 to 4:15 PM<\/td>\niPSC-based disease modelling of haematological diseases<\/td>\nR V Shaji
<\/strong>Centre for Stem Cell Research (A unit of inStem, Bengaluru) and CMC, Vellore, India <\/td>\n<\/tr>\n
4:15 to 4:45 PM<\/td>\nQuality control for human stem cell lines for clinical application<\/td>\nGlyn Stacey<\/strong>
International Stem Cell Banking, Initiative, UK<\/td>\n<\/tr>\n
4:45 to 5:15 PM<\/td>\nModelling human neurodevelopmental disorders using iPSC technology<\/td>\nRaghu Padinjat<\/strong>
National Centre for Biological Sciences, Bangalore, India<\/td>\n<\/tr>\n
5:15 to 6:00 PM<\/td>\nPoster presentation and Industry Exhibition <\/strong><\/span><\/td>\n<\/tr>\n
 <\/td>\n <\/td>\n<\/tr>\n
                                                                                                                Session-7: TECHNOLOGY ADVANCES                                                                                                        <\/strong><\/span>Chair- Srujan Kumar Marepally <\/strong>
<\/strong><\/td>\n<\/tr>\n
Indian Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
6:00 to 6:30 PM<\/td>\nHIV gene therapy: A time to prevent, a time to silence, and finally, the time to cure<\/td>\nPriti Kumar<\/strong>
Yale University, New Haven, US<\/td>\n<\/tr>\n
6:30 to 7:00 PM<\/td>\nImproving access to ATMPs in India through robust industrial operations <\/td>\nGiridhar K Chenji<\/strong>
Immuneel Therapeutics Private Limited, Bangalore, India<\/td>\n<\/tr>\n
7:00 to 7:30 PM<\/td>\nIn vivo HSC gene editing for hemoglobinopathies<\/td>\nChang Li<\/strong>
University of Washington, Seattle, WA<\/td>\n<\/tr>\n
7:30 to 8:00 PM<\/td>\nThe quest for next generation lipid nanoparticles for cell-specific delivery of mRNA<\/td>\nGaurav Sahay
<\/strong>Oregon State University, Oregon, US<\/td>\n<\/tr>\n
\n

KEYNOTE<\/b> ADDRESS<\/b><\/span><\/p>\n

                   Chair: Mammen Chandy<\/b><\/strong> <\/b><\/span>   <\/span>             <\/b>
<\/strong><\/p>\n<\/td>\n<\/tr>\n

Indian Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
8:00 to 9:00 PM<\/td>\nClinical Cardiac Gene Therapy Comes of Age<\/td>\nRoger Hajjar<\/strong>
Gene and Cell Therapy Institute, Mass General Brigham, Cambridge, USA<\/td>\n<\/tr>\n
End of Day-2<\/strong><\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/h2>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

DAY-3: Satur<\/b>day<\/b>, <\/b>2<\/b>nd  <\/sup><\/b>SEPTEMBER, 2023<\/b><\/span><\/h2>\n<\/td>\n<\/tr>\n

\n

Session-8: GENE EDITING<\/strong><\/span><\/p>\n

Chair: Souvik Maiti<\/strong><\/p>\n<\/td>\n<\/tr>\n

Indian Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
2:00 to 2:30 PM<\/td>\nBi-functional gene editing of the Hematopoietic Stem and Progenitor Cells for \u03b2-hemoglobinopathies gene therapy <\/td>\nSaravanabhavan Thangavel       <\/strong>                                                                                                Centre for Stem Cell Research (A unit of inStem, Bengaluru), Vellore, India <\/td>\n<\/tr>\n
2:30 to 3:00 PM<\/td>\nTargeted genome-engineering of hematopoietic stem progenitor cells for reactivation of fetal hemoglobin<\/td>\nSivaprakash Ramalingam<\/strong>
CSIR-Institute of Genomics and Integrative Biology (IGIB), New Delhi, India<\/td>\n<\/tr>\n
3:00 to 3:30 PM<\/td>\nPrecision genome editing for beta-hemoglobinopathies<\/td>\nMohankumar Murugesan
<\/strong>Centre for Stem Cell Research (A unit of inStem, Bengaluru), Vellore, India<\/td>\n<\/tr>\n
3:30 to 3:45 PM<\/td>\n     Break<\/span><\/strong><\/td>\n<\/tr>\n
3:45 to 4:30 PM<\/td>\nPoster presentation and Industry Exhibition <\/span><\/strong><\/td>\n<\/tr>\n
\n

Session-9: GENE THERAPY<\/strong><\/span><\/p>\n

Chair: R V Shaji<\/strong><\/p>\n<\/td>\n<\/tr>\n

Indian Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
4:30 to 5:00 PM<\/td>\nDevelopment of genome-modified generation Z (GenZ) single-stranded AAV vectors with improved transgene expression<\/td>\nArun Srivastava<\/strong>
University of Florida, Florida, USA<\/td>\n<\/tr>\n
5:00 to 5:30 PM<\/td>\nAAV Dual Vector Designs for Therapeutic Applications<\/td>\nArkasubhra Ghosh<\/strong>
Narayana Nethralaya Foundation, Bengaluru, India<\/td>\n<\/tr>\n
5:30 to 6:00 PM<\/td>\nComplexity of Cellular Immune Responses in The Liver<\/td>\nRoland W. Herzog<\/strong>
Indiana University, Indianapolis, USA<\/td>\n<\/tr>\n
End of Day-3<\/strong><\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n

\u00a0<\/h3>\n

Video Summary of the program<\/b><\/span>\u00a0<\/b><\/span><\/i> \u2013 Click to view \/ Download<\/strong><\/span><\/a><\/h3>\n

CGTS 2023 SCIENTIFIC PROGRAM<\/strong><\/em> \u2013 Click to view \/ Download<\/strong><\/a><\/p>\n

CGTS 2023 ABSTRACT BOOK \u2013 Click to view \/ download<\/a><\/p>\n

CGTS 2023 E-POSTER \u2013 Click to view \/ download<\/a>\u00a0 \u00a0<\/p>\n\n\n\n